Marketing Specialist Rare disease (M/F)
Infos sur l'emploi
- Date de publication :25 octobre 2024
- Taux d'activité :100%
- Type de contrat :Temporaire
- Langue :allemand (Courant), anglais (Courant)
- Lieu de travail :Bulle
We are thrilled of recruiting a Marketing specialist/expert for UCB. UCB is focused on the discovery and development of innovative medecines and solutions for people living with severe diseases in immunology and neurology. The team based in the Alps region (Austria & Switzerland) is passionate about making a difference in the epilepsy and rare disase community improving patient health outcomes.
Your mission:
- Drive localization and implentation of the EU and regional Rare & Epilepsy strategy and action plan in alignement with Alps Rare&Epi Lead and Alps Marketing Lead;
- Develop local marketing solutions across different and various channels;
- Manage marketing campaigns via several channels including digital, print and events;
- Build, monitor and track implementation of Marketing strategies via KPIs to measure their value and impact;
- Support the Marketing team in the development of the local Rare & Epi Integrated Strategic Planning (ISP).
Functie-eisen
Your profile:
- Degree in Marketing, in Life Sciences or equivalent;
- At least 5 years of relevant experience in Marketing ideally in pharma or biotech;
- Excellent communication skills, creative and problem-solving abilities;
- Ability to work independently as well as being part of a multicultural team;
- Proficiency in MS Suite and interest for digital tools (experience with Veeva system is a plus);
- Excellent written and verbal coomunication skills in German and English. French and / or Italian is a plus.
- Passionate for making a positive impact on patients lives and alligned with the core values of UCB.
This is a 100% remote role with trips to be planned throughout the year.
We can offer you a new challenge in a diverse and innovative environment. Have we sparked your interest? Then we look forward to receiving your online application.